Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: A retrospective study of the efficacy of intense pulsed light delivered by the Lacrystim® for meibomian gland dysfunction therapy

Fig. 2

Boxplot of non-invasive break-up-time (NIBUT) (A), ocular surface disease index (OSDI) (B) Oxford score (C) and interferometry (D) changes over time. Thick horizontal lines show the distribution median; boxes, the interquartile range (IQR); and individual points, the outliers between 1.5 and 3 times the IQR. Whiskers mark the highest and lowest non-outlying values. A Median NIBUT increased with time: 8.6 at day (D) 0, 8.7 at D45, 9.3 at 3rd month and 9.6 at 6th month. B OSDI score significantly improved over time with medians at 42.7 at D0, 34.2 at D45, 34.3 at 3rd month and 35.4 at 6th month. C Oxford score improved over time with medians at 2.0 at D0, 1.0 at D45, 1.0 at 3rd month and 1.0 at 6th month. D Interferometry significantly improved with a constant median over time at 30 at D0, D45, 3rd month and 6th month

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us